When it comes to switching from a biologic to a biosimilar drug, patient choice and engagement is extremely important, according to Durhane Wong-Rieger, president and chief executive officer of the Canadian Organization for Rare Disorders. “While a patient’s on a drug, they need to be continuously monitoring,” she said during a session at Benefits Canada’s 2019 Calgary Drug […]
Alongside Fluor Canada’s recent move to a flexible benefits plan, it also introduced a managed drug formulary, which includes generic substitution, prior authorization, lifetime maximums and an annual out-of-pocket maximum. While the organization was hesitant to make the change, it knew it was necessary to help control drug costs, said Michelle Ginter, senior human resources […]
When it came to asking his employer to add continuous glucose monitoring to its benefits package, John Whitehead, a level-two food server at Niagara Casinos, went all in. He’s had type 1 diabetes for years, and lived through many technological developments to help manage his condition. While he says blood glucose monitoring represented a major improvement, it […]
For its increased focus on complete reviews of its disability policy and overall absence management program, Scotiabank took home the absence management award at Benefits Canada’s 2019 Workplace Benefits Awards in Toronto on Oct. 17. Three and a half years ago, Scotiabank went through a complete audit of its disability program, part of its overall best practice review for these […]
When it comes to health-care spending in Canada, there isn’t a lot of variance between provinces, according to Joe Farago, executive director of private payers and investment at Innovative Medicines Canada. In a session at Benefits Canada’s 2019 Halifax Benefits Summit on Sept. 24, he said prescription drugs’ percentage of the total health-care budget has been fairly consistent, at 15 […]
With around 270,000 individuals currently affected by irritable bowel disease, Canada has the highest prevalence in the world, according to Mina Mawani, president and chief executive officer of Crohn’s and Colitis Canada, during a session at Benefits Canada’s 2019 Halifax Benefits Summit on Sept. 24. “And this is going to increase significantly. We’re going to be […]
As the prevalence of diabetes continues to rise, so do the increases in cost, according to Adam Hotchkiss, medical science liaison at Novo Nordisk Canada, during Benefits Canada‘s 2019 Halifax Benefits Summit on Sept. 24. “In 2010, $11.7 billion was spent in Canada on the treatment of diabetes as well as its complications,” he said. “This is […]
Since diabetes is a progressive disease, it’s important to get treatment in the middle, according to Dr. Thomas Ransom, endocrinologist at the Nova Scotia Health Authority, during Benefits Canada‘s 2019 Halifax Benefits Summit on Sept. 24. If diabetes is under-treated, blood sugars go up and stick to things — eyes, kidneys, nerves, feet, he said. And if it’s […]
The requirement to measure and report on the quality of the health-care services delivered by providers is growing, alongside the redefined nature of the relationship between payers and health-care providers, such as pharmacy, said Ned Pojskic, leader of pharmacy and health provider relations at Green Shield Canada. “This system . . . is designed in its very nature […]
Employers, health-care professionals and people living with obesity disagree on how the disease develops, how to manage it and who’s responsible for treatment, according to a new study by Obesity Canada. The study, which was published in the journal Clinical Obesity this month, surveyed 150 employers, 395 physicians and 2,000 individuals living with obesity. More than […]